Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging Journal Article


Authors: Tee, S. S.; Kim, N.; Cullen, Q.; Eskandari, R.; Mamakhanyan, A.; Srouji, R. M.; Chirayil, R.; Jeong, S.; Shakiba, M.; Kastenhuber, E. R.; Chen, S.; Sigel, C.; Lowe, S. W.; Jarnagin, W. R.; Thompson, C. B.; Schietinger, A.; Keshari, K. R.
Article Title: Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging
Abstract: The ability to break down fructose is dependent on ketohexokinase (KHK) that phosphorylates fructose to fructose-1-phosphate (F1P). We show that KHK expression is tightly controlled and limited to a small number of organs and is down-regulated in liver and intestinal cancer cells. Loss of fructose metabolism is also apparent in hepatocellular adenoma and carcinoma (HCC) patient samples. KHK overexpression in liver cancer cells results in decreased fructose flux through glycolysis. We then developed a strategy to detect this metabolic switch in vivo using hyperpolarized magnetic resonance spectroscopy. Uniformly deuterating [2-13C]-fructose and dissolving in D2O increased its spin-lattice relaxation time (T1) fivefold, enabling detection of F1P and its loss in models of HCC. In summary, we posit that in the liver, fructolysis to F1P is lost in the development of cancer and can be used as a biomarker of tissue function in the clinic using metabolic imaging.
Journal Title: Science Advances
Volume: 8
Issue: 14
ISSN: 2375-2548
Publisher: Amer Assoc Advancement Science  
Date Published: 2022-04-08
Start Page: eabm7985
Language: English
DOI: 10.1126/sciadv.abm7985
PUBMED: 35385296
PROVIDER: scopus
PMCID: PMC8985914
DOI/URL:
Notes: Author Chen, S. is incorrectly listed as an MSK author in publisher record and in PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics